Correlation Between Novo Nordisk and Novo Nordisk
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and Novo Nordisk AS, you can compare the effects of market volatilities on Novo Nordisk and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Novo Nordisk.
Diversification Opportunities for Novo Nordisk and Novo Nordisk
0.99 | Correlation Coefficient |
No risk reduction
The 3 months correlation between Novo and Novo is 0.99. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Novo Nordisk go up and down completely randomly.
Pair Corralation between Novo Nordisk and Novo Nordisk
Considering the 90-day investment horizon Novo Nordisk AS is expected to under-perform the Novo Nordisk. But the stock apears to be less risky and, when comparing its historical volatility, Novo Nordisk AS is 1.35 times less risky than Novo Nordisk. The stock trades about -0.29 of its potential returns per unit of risk. The Novo Nordisk AS is currently generating about -0.21 of returns per unit of risk over similar time horizon. If you would invest 11,700 in Novo Nordisk AS on August 23, 2024 and sell it today you would lose (1,350) from holding Novo Nordisk AS or give up 11.54% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Novo Nordisk AS vs. Novo Nordisk AS
Performance |
| Timeline |
| Novo Nordisk AS |
| Novo Nordisk AS |
Novo Nordisk and Novo Nordisk Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Novo Nordisk and Novo Nordisk
The main advantage of trading using opposite Novo Nordisk and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.| Novo Nordisk vs. Regeneron Pharmaceuticals | Novo Nordisk vs. Crispr Therapeutics AG | Novo Nordisk vs. Sarepta Therapeutics | Novo Nordisk vs. Intellia Therapeutics |
| Novo Nordisk vs. Nuvalent | Novo Nordisk vs. Arcellx | Novo Nordisk vs. Vaxcyte | Novo Nordisk vs. Viridian Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |